Page last updated: 2024-10-26

valproic acid and Heart Disease, Ischemic

valproic acid has been researched along with Heart Disease, Ischemic in 4 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Svennerholm, K1
Bergh, N1
Larsson, P1
Jern, S1
Johansson, G1
Biber, B1
Haney, M1
Kuai, Q1
Wang, C1
Wang, Y2
Li, W1
Zhang, G1
Qiao, Z1
He, M1
Wang, X1
Jiang, X1
Su, L1
He, Y1
Ren, S1
Yu, Q1
Ferrari, R1
Merli, E1
Cicchitelli, G1
Mele, D1
Fucili, A1
Ceconi, C1
Meerson, FZ1
Gimrikh, EO1
Gutsol, LIa1
Popov, SV1
Plekhanov, IG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Estudio clínico Fase III Para Evaluar la Eficacia terapéutica en Pacientes Mexicanos Con Dislipidemia Mediante el Uso vía Oral de L-Carnitina + Atorvastatina Comparado Con Atorvastatina[NCT03696940]Phase 3120 participants (Actual)Interventional2018-05-28Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for valproic acid and Heart Disease, Ischemic

ArticleYear
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Annals of the New York Academy of Sciences, 2004, Volume: 1033

    Topics: Cardiotonic Agents; Cardiovascular Diseases; Carnitine; Humans; Kidney Failure, Chronic; Liver; Myoc

2004

Other Studies

3 other studies available for valproic acid and Heart Disease, Ischemic

ArticleYear
Histone deacetylase inhibitor treatment increases coronary t-PA release in a porcine ischemia model.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Animals; Disease Models, Animal; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Myocardial Isc

2014
Energy metabolism regulated by HDAC inhibitor attenuates cardiac injury in hemorrhagic rat model.
    Scientific reports, 2016, 12-02, Volume: 6

    Topics: Animals; Cell Line; Disease Models, Animal; Energy Metabolism; Hemorrhage; Histone Deacetylase Inhib

2016
[The anti-arrhythmic efficacy of sodium valproate].
    Kardiologiia, 1992, Volume: 32, Issue:7-8

    Topics: Adolescent; Adult; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Drug Evaluation; Electrocar

1992